Skip to main content
Top

12-12-2024 | Alzheimer Disease | Podcast

Episode 14

Diagnostic criteria for AD

Can we define Alzheimer's disease as a purely biological entity?

print
PRINT
insite
SEARCH
Guest:
Dr. Nicolas Villain
Host:
Katrina Brown

Blood-based biomarkers are set to make biological assessment of Alzheimer's disease much quicker and more accessible than has been possible with imaging and CSF biomarkers. Does this mean the disease can now be defined as a purely biological entity? 

Dr. Nicolas Villain outlines why it is still so important to consider both clinical symptoms and biological findings when making a diagnosis. 

« Previous episode: Episode 13: Advances in MASLD and MASH

Next episode: Episode 15: Breastfeeding after breast cancer »

Further reading


print
PRINT

Related topics

How can you integrate PET into your practice? (Link opens in a new window)

PET imaging is playing an increasingly critical role in managing AD. Our expert-led program will empower you with practical strategies and real-world case studies to effectively integrate it into clinical practice.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Healthcare IME
Register your interest

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now
Video